Neil Gregory Almstead - Jan 8, 2024 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Jan 8, 2024
Transactions value $
-$83,950
Form type
4
Date filed
1/10/2024, 04:03 PM
Previous filing
Feb 2, 2023
Next filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$35.4K -1.24K -1.91% $28.64 63.3K Jan 8, 2024 Direct F1, F2
transaction PTCT Common Stock Sale -$1.52K -53 -1.36% $28.64 3.83K Jan 8, 2024 By Spouse F3, F4
transaction PTCT Common Stock Sale -$44.1K -1.52K -2.4% $29.01 61.8K Jan 9, 2024 Direct F5
transaction PTCT Common Stock Sale -$2.9K -100 -2.61% $29.01 3.73K Jan 9, 2024 By Spouse F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.
F2 Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.
F3 Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs.
F4 Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.
F5 Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.
F6 Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs and the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs.